Browse Data and Analysis

Sri Lanka’s agricultural biotechnology policies remain unchanged. Over the past year, there has been no progress in the approval of its draft Biosafety Act, which establishes a system to protect biodiversity, the environment and human, plant and animal health while minimizing the risks of biotechnology.

The Government of Tanzania continues to implement strict liability requirements on the commercialization of genetically engineered products, as outlined in the 2009 Biosafety Regulations. There are no genetically engineered products imported or commercialized in Tanzania. However, applied biotechnology is used for medicine and public health.